Celgene, PHA to study combo therapy

CELG and PHA will conduct a Phase II study to assess the safety of CELG's Thalomid thalidomide in combination with Camptosar irinotecan from Pharmacia (PHA), and 5-flourouracil (5-FU) and leucovorin i...